An inquest into the death of a 24-year-old scaffolder has found that the patient was “failed” by his healthcare providers.

Verve Therapeutics, a healthcare company focused on improving cardiovascular outcomes through gene-editing technology, has raised $63 million in Series A2 financing.

Cardiology has seen its revenue and utilization take significant hits as a result of the COVID-19 pandemic.

The COVID-19 pandemic hit rural hospitals especially hard—and that’s bad news for patients in areas already associated with poor cardiovascular outcomes.

As the COVID-19 pandemic rages on, it is difficult to know just how many healthcare workers have lost their lives battling this deadly virus. According to a new project, the number currently sits at 586—and it is expected to continue rising.

Do patients in the United States have sufficient access to TAVR centers?

Bio Conscious has announced that its AI-powered Diabits app can predict blood glucose levels a full hour into the future—and it has the data to prove it.

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Operators who performed at least 16 uLMS-PCIs per year were associated with improved survival.

The researchers explored data from orthotopic heart transplant patients who were hospitalized for COVID-19 at one of two facilities.